Published in Blood Weekly, June 26th, 1995
SYBD is developing three biomedical products: an implantable glucose biosensor to help diabetics regulate their blood-sugar levels; Oxycyte, an oxygen-carrying universal synthetic blood substitute; and Fluorovent, a liquid ventilation product that also carries and exchanges high concentrations of oxygen. The synthetic blood product and liquid ventilation formula are based on fluorocarbon technology.
SYBD contracted with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.